Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9407968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.

  1997cited by this paper
• Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition.

  1997cited by this paper
• Incidence of p53 and Ha‐ras gene mutations in chemically induced rat mammary carcinomas

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis.

  1996cited by this paper
• Improved purification and yields of RNA by RNeasy.

  1996cited by this paper
• Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.

  1996cited by this paper
• Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells.

  1996cited by this paper
• Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb.

  1996cited by this paper
• Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*)

  1995cited by this paper
• Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

  1995cited by this paper
• Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells.

  1995cited by this paper
• Delay of dimethylbenz[a]anthracene‐induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein

  1995cited by this paper
• Mammary tumor suppression by transforming growth factor beta 1 transgene expression.

  1995cited by this paper
• Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor.

  1995cited by this paper
• Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.

  1994cited by this paper
• Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.

  1994cited by this paper
• Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.

  1994cited by this paper
• Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.

  1994cited by this paper
• Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

  1994cited by this paper
• Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.

  1993cited by this paper
• Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.

  1993cited by this paper
• Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.

  1993cited by this paper
• Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.

  1993cited by this paper
• Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation.

  1993cited by this paper
• TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector

  1992cited by this paper
• Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands.

  1992cited by this paper
• FVB/N: an inbred mouse strain preferable for transgenic analyses.

  1991cited by this paper
• Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development.

  1991cited by this paper
• The transforming growth factor-beta family.

  1990cited by this paper
• Effects of transforming growth factor beta on growth of human mammary epithelial cells in culture.

  1989cited by this paper
• Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture.

  1989cited by this paper
• Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.

  1988cited by this paper
• Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter.

  1988cited by this paper
• Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.

  1988cited by this paper
• Reversible inhibition of mammary gland growth by transforming growth factor-beta.

  1987cited by this paper
• Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts.

  1984cited by this paper
• Serial transplantation of chemical carcinogen-induced mouse mammary ductal dysplasias.

  1979cited by this paper
• DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

  1979cited by this paper

• Noncanonical Wnt/Ror2 Signaling Regulates Basal Cell Fidelity and Branching Morphogenesis in the Mammary Gland

  2025cites this paper
• C1orf106 (INAVA) Is a SMAD3-Dependent TGF-β Target Gene That Promotes Clonogenicity and Correlates with Poor Prognosis in Breast Cancer

  2024cites this paper
• The targeted next-generation sequence revealed SMAD4, AKT1, and TP53 mutations from circulating cell-free DNA of breast cancer and its effect on protein structure – A computational approach

  2023cites this paper
• SRC kinase-mediated signaling pathways and targeted therapies in breast cancer

  2022cites this paper
• Targeting transforming growth factor‐β signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin

  2022cites this paper
• The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway

  2022cites this paper
• Dimethylbenz(a)anthracene-induced mammary tumorigenesis in mice.

  2021cites this paper
• SMAD7 enhances adult β-cell proliferation without significantly affecting β-cell function in mice

  2020cites this paper
• Urethane-induced Mammary Carcinogenesis Susceptibility in Transgenic Mice Expressing a Dominant-negative TGF-β Type II Receptor

  2020cites this paper
• The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment

  2019cites this paper
• Dachshund Depletion Disrupts Mammary Gland Development and Diverts the Composition of the Mammary Gland Progenitor Pool

  2018cites this paper
• TGF-β-Dependent Growth Arrest and Cell Migration in Benign and Malignant Breast Epithelial Cells Are Antagonistically Controlled by Rac1 and Rac1b

  2017cites this paper
• Model of vascular desmoplastic multispecies tumor growth.

  2017cites this paper
• The Terminal End Bud: the Little Engine that Could

  2017cites this paper
• The crossroads of breast cancer progression: insights into the modulation of major signaling pathways

  2017cites this paper
• Carcinogen 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis is accelerated in Smad3 heterozygous mice compared to Smad3 wild type mice

  2016cites this paper
• A synopsis of factors regulating beta cell development and beta cell mass

  2016cites this paper
• Stromal gene expression defines poor-prognosis subtypes in colorectal cancer

  2015cites this paper
• TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis

  2015cites this paper
• SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor*

  2015cites this paper
• Lung cancer stem cells: Molecular features and therapeutic targets.

  2014cites this paper
• TGF-β: duality of function between tumor prevention and carcinogenesis.

  2014cites this paper
• Attenuation of TGF-β signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model.

  2014cites this paper
• Cytokine Networks That Mediate Epithelial Cell-Macrophage Crosstalk in the Mammary Gland: Implications for Development and Cancer

  2014cites this paper
• Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.

  2014cites this paper
• Factors Expressed by Murine Embryonic Pancreatic Mesenchyme Enhance Generation of Insulin-Producing Cells From hESCs

  2013cites this paper
• The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T Cells

  2013cites this paper
• TGF-beta antiproliferative effects in tumor suppression.

  2012cites this paper
• The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis

  2012cites this paper
• Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells

  2012cites this paper
• TGF-beta antiproliferative effects in tumor suppression Stephan

  2012cites this paper
• Regulation of TGF-B1-induced apoptosis and epithelial-mesenchymal transition by matrix rigidity

  2011cites this paper
• Functional Transforming Growth Factor-β Receptor Type II Expression by CD4+ T Cells in Peyer's Patches Is Essential for Oral Tolerance Induction

  2011cites this paper
• TGF-beta biology in mammary development and breast cancer.

  2011cites this paper
• High-resolution multiphoton imaging of tumors in vivo.

  2011cites this paper
• The complexities of TGF-β action during mammary and squamous cell carcinogenesis.

  2011cites this paper
• The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.

  2010cites this paper
• Lipoxin A4 Inhibits Transition of Epithelial to Mesenchymal Cells in Proximal Tubules

  2010cites this paper
• Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner.

  2010cites this paper
• Progress and applications of mouse models for human lung cancer

  2010cites this paper
• Inhibiting breast cancer progression by exploiting TGFbeta signaling.

  2010cites this paper
• The identification of stem cells in human liver diseases and hepatocellular carcinoma.

  2010cites this paper
• Resident and recruited stroma contribute to castrate resistant prostate cancer.

  2010cites this paper
• A Functional Connection between pRB and Transforming Growth Factor β in Growth Inhibition and Mammary Gland Development

  2009cites this paper
• Liver stem cells and hepatocellular carcinoma

  2009cites this paper
• A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells.

  2009cites this paper
• Cancer gene discovery in mouse and man

  2009cites this paper
• Role of the Type III TGF-beta Receptor Cytoplasmic Domain in Breast Cancer Progression

  2009cites this paper
• Melanoma and nonmelanoma skin cancers and the immune system.

  2008cites this paper
• Signal Transduction in Transgenic Mouse Models of Human Breast Cancer—Implications for Human Breast Cancer

  2008cites this paper
• Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype.

  2008cites this paper
• Tumor-associated EGFR over-expression specifically activates Stat3 and Smad7 resulting in desensitization of TGF-β signaling

  2008cites this paper
• The role of cancer stem cells in neoplasia of the lung: past, present and future

  2008cites this paper
• Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.

  2008cites this paper
• Infrequently methylated event at sites −362 to −142 in the promoter of TGFβR1 gene in non-small cell lung cancer

  2008cites this paper
• Molecular mechanisms of head and neck cancer

  2008cites this paper
• Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.

  2007cites this paper
• Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations

  2007cites this paper
• Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model.

  2007cites this paper
• Lung cancer and lung stem cells: strange bedfellows?

  2007cites this paper
• Inhibition of the TGF-beta signaling pathway in tumor cells.

  2007cites this paper
• Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function

  2007cites this paper
• Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.

  2007cites this paper
• Prognostic significance of TGFbeta-1 and pSmad2/3 in breast cancer patients with T1-2,N0 tumours.

  2007cites this paper
• Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.

  2007cites this paper
• The role of TGF-beta superfamily during T cell development: new insights.

  2007cites this paper
• Targeting aberrant TGF-beta signaling in pre-clinical models of cancer.

  2007cites this paper
• Pro-metastasis function of TGFbeta mediated by the Smad pathway.

  2006cites this paper
• Determination of TGFβ1 protein level in human primary breast cancers and its relationship with survival

  2006cites this paper
• β3 Integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells

  2006cites this paper
• RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.

  2006cites this paper
• Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.

  2006cites this paper
• Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo

  2006cites this paper
• TGF-beta and cancer.

  2006cites this paper
• Transforming growth factor-beta in cancer and metastasis.

  2006cites this paper
• Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo.

  2006cites this paper
• Pro‐metastasis function of TGFβ mediated by the smad pathway

  2006cites this paper
• Homozygous deletion of SMAD4 in breast cancer cell lines and invasive ductal carcinomas

  2006cites this paper
• Increased expression of TGF-β1 reduces tumor growth of human U-87 Glioblastoma Cells in vivo

  2006cites this paper
• Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.

  2005cites this paper
• Smad Acetylation: A New Level of Regulation in TGF-Beta Signaling

  2005cites this paper
• Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.

  2005cites this paper
• Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.

  2005cites this paper
• Mouse models for human lung cancer.

  2005cites this paper
• Transforming Growth Factor Beta and breast cancer.

  2005cites this paper
• Proteomics of TGF-β signaling and its impact on breast cancer

  2005cites this paper
• Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression.

  2005cites this paper
• Disruption of the TGF-beta pathway and modeling human cancer in mice.

  2005cites this paper
• Mouse models of transforming growth factor beta impact in breast development and cancer.

  2005cites this paper
• Transforming growth factor-beta1 and disorders of the lung.

  2005cites this paper
• Up-regulation of beta-catenin in external auditory canal cholesteatoma.

  2005cites this paper
• Activated type I TGFbeta receptor (Alk5) kinase confers enhanced survival to mammary epithelial cells and accelerates mammary tumor progression

  2005cites this paper
• Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.

  2005cites this paper
• Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma.

  2005cites this paper
• Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.

  2005cites this paper
• Stromal fibroblasts in cancer initiation and progression

  2004cites this paper
• Transforming Growth Factor-β Pathway Serves as a Primary Tumor Suppressor in CD8+ T Cell Tumorigenesis

  2004cites this paper
• Overexpression of HER2 (erbB2) in Human Breast Epithelial Cells Unmasks Transforming Growth Factor β-induced Cell Motility*

  2004cites this paper
• Attenuated type II TGF‐β receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination

  2004cites this paper
• Development of TGF-beta signalling inhibitors for cancer therapy.

  2004cites this paper